← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Dub Therapeutics Inc.
Syracuse, NY
$2,809,211
Total funding
2
Grants
Funding over time
peak $1.1M · FY2023–25$2M$1.5M$1M$500K$0
'23
'24
'25
Funding mix
By agency
NIH$2,809,211 · 2
By mechanism
R44$2,809,211 · 2
Investigators at Dub Therapeutics Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
A novel siRNA therapeutic to prevent scarring and bleb failure after trabeculectomy$1,009,285
R44 · FY2025 · EY
A single dose anti-scarring therapeutic for the cornea$917,935
R44 · FY2024 · EY
A single dose anti-scarring therapeutic for the cornea$699,991
R44 · FY2023 · EY
A single dose anti-scarring therapeutic for the cornea$182,000
R44 · FY2024 · EY